![Jerry Kanellos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 068 $ al 31/08/2026
Jerry Kanellos currently works at Immuron Canada Ltd., as Director from 2018 and Immuron Ltd., as Chief Operating & Scientific Officer from 2022.
Dr. Kanellos also formerly worked at CSL Ltd., as Head-Research & Development and Transbio Ltd., as Chief Operating Officer from 2008 to 2012.
Dr. Kanellos received his doctorate degree from the University of Melbourne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMURON LIMITED 0,1 % | 08/09/2026 | 333.000 ( 0,1 % ) | 9 068 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMURON LIMITED | Director de Operaciones | 01/07/2015 |
Immuron Canada Ltd. | Director/Miembro de la Junta | 01/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Transbio Ltd. | Director de Operaciones | 01/01/2012 |
| CSL LIMITED | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
 Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Transbio Ltd. | |
Immuron Canada Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
